FDA Status Update
FDA Status Update
April 17, 2023
Alvotech has been informed by the U.S. Food and Drug Administration (FDA) that the responses provided to the FDA Form 483 on April 3, 2023, following the conclusion of the reinspection of the company’s Reykjavik facility on March 17, 2023, are currently under review.
Alvotech Investor Relations
Benedikt Stefansson
alvotech.ir[at]alvotech.com
